AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 170 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 8.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $241,000 | -31.3% | 11,980 | -23.0% | 0.05% | -18.5% |
| Q1 2017 | $351,000 | -38.3% | 15,555 | -4.8% | 0.06% | -39.8% |
| Q4 2016 | $569,000 | +25.1% | 16,345 | -11.9% | 0.11% | +24.1% |
| Q3 2016 | $455,000 | -34.8% | 18,545 | -36.4% | 0.09% | -31.5% |
| Q2 2016 | $698,000 | -3.3% | 29,170 | -5.5% | 0.13% | -5.2% |
| Q1 2016 | $722,000 | +39.9% | 30,863 | +80.7% | 0.13% | +41.1% |
| Q4 2015 | $516,000 | – | 17,082 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |